Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionJacobi Capital Management LLC
Latest Disclosed Ownership23,498 shares
Latest Disclosed Value $ 3,274,850
Jacobi Capital Management LLC reports 1.38% increase in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Jacobi Capital Management LLC filed a 13F-HR form disclosing ownership of 23,498 shares of Gilead Sciences, Inc. (CH:GILD) valued at $3,274,850 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 23,177 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.38% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 23,498 321 1.38 3,275 15.12 0.1829
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 23,177 -2 -0.01 2,845 10.58 0.1649
2025-11-07 2025-09-30 13F GILEAD SCIENCES COM 375558103 23,179 46 0.20 2,573 0.31 0.1566
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 23,133 -13 -0.06 2,565 -1.12 0.1702
2025-05-27 2025-03-31 13F GILEAD SCIENCES COM 375558103 23,146 -3,924 -14.50 2,594 3.72 0.1913
2025-02-05 2024-12-31 13F GILEAD SCIENCES COM 375558103 27,070 -42 -0.15 2,501 9.99 0.1868
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 27,112 8,246 43.71 2,273 75.66 0.1718
2024-08-09 2024-06-30 13F GILEAD SCIENCES COM 375558103 18,866 1,802 10.56 1,294 3.60 0.1124
2024-05-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 17,064 3 0.02 1,250 -9.62 0.1155
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 17,061 98 0.58 1,382 8.73 0.1418
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 16,963 -899 -5.03 1,271 -7.63 0.1437
2023-08-08 2023-06-30 13F GILEAD SCIENCES COM 375558103 17,862 -1,601 -8.23 1,377 -14.75 0.1540
2023-05-05 2023-03-31 13F GILEAD SCIENCES COM 375558103 19,463 -250 -1.27 1,615 -4.61 0.1916
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 19,713 -681 -3.34 1,692 34.50 0.2116
2022-11-09 2022-09-30 13F GILEAD SCIENCES COM 375558103 20,394 289 1.44 1,258 1.29 0.1722
2022-08-05 2022-06-30 13F GILEAD SCIENCES COM 375558103 20,105 1,439 7.71 1,242 11.99 0.1652
2022-05-06 2022-03-31 13F GILEAD SCIENCES COM 375558103 18,666 2,321 14.20 1,109 -6.57 0.1325
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 16,345 1,173 7.73 1,187 11.98 0.1415
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 15,172 -270 -1.75 1,060 -0.28 0.1348
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 15,442 -75 -0.48 1,063 5.98 0.1405
2021-05-11 2021-03-31 13F GILEAD SCIENCES COM 375558103 15,517 112 0.73 1,003 3.19 0.1480
2021-02-08 2020-12-31 13F GILEAD SCIENCES COM 375558103 15,405 2,145 16.18 972 18.83 0.1534
2020-10-30 2020-09-30 13F GILEAD SCIENCES COM 375558103 13,260 1,189 9.85 818 -11.47 0.1435
2020-08-04 2020-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 12,071 123 1.03 924 -1.39 0.1727
2020-07-27 2020-06-30 13F GILEAD SCIENCES COM 375558103 12,071 123 924 172,748.3819
2020-04-24 2020-03-31 13F GILEAD SCIENCES COM 375558103 11,948 -96 -0.80 937 21.85 0.2014
2020-02-03 2019-12-31 13F GILEAD SCIENCES COM 375558103 12,044 297 2.53 769 0.79 0.1403
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 11,747 369 3.24 763 -0.65 0.1510
2019-08-07 2019-06-30 13F GILEAD SCIENCES COM 375558103 11,378 9,530 515.69 768 540.00 0.1560
2019-05-13 2019-03-31 13F GILEAD SCIENCES COM 375558103 1,848 -449 -19.55 120 -16.67 0.0306
2019-02-11 2018-12-31 13F GILEAD SCIENCES COM 375558103 2,297 -719 -23.84 144 -38.20 0.0394
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 3,016 418 16.09 233 26.63 0.0623
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 2,598 583 28.93 184 25.17 0.0532
2018-05-03 2018-03-31 13F GILEAD SCIENCES COM 375558103 2,015 434 27.45 147 24.58 0.0441
2018-02-05 2017-12-31 13F GILEAD SCIENCES COM 375558103 1,581 943 147.81 118 126.92 0.0382
2017-11-02 2017-09-30 13F GILEAD SCIENCES COM 375558103 638 68 11.93 52 30.00 0.0176
2017-08-10 2017-06-30 13F GILEAD SCIENCES COM 375558103 570 117 25.83 40 33.33 0.0155
2017-05-26 2017-03-31 13F GILEAD SCIENCES COM 375558103 453 2 0.44 30 -9.09 0.0154
2017-02-08 2016-12-31 13F GILEAD SCIENCES COM 375558103 451 -125 -21.70 33 -26.67 0.0201
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 576 2 0.35 45 -8.16 0.0213
2016-11-14 2016-06-30 13F GILEAD SCIENCES COM 375558103 574 574 49 0.0245
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.